Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McInnes

Showing results (211-220 of 537) with videos related to

Pageof 54
Sort By:
Rheumatology and Therapy|August 9, 2024
Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect ComparisonPhilip J Mease, Richard B Warren, Peter Nash, et al.
The Lancet. Rheumatology|January 17, 2024
Precision medicine in psoriatic arthritis: how should we select targeted therapies?Hussein Al-Mossawi, Leonie S Taams, Carl S Goodyear, et al.
Rheumatology (Oxford, England)|July 15, 2016
MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid ArthritisAziza Elmesmari, Alasdair R Fraser, Claire Wood, et al.
Rheumatology (Oxford, England)|July 28, 2014
The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cellsAndrew M Platt, Robert A Benson, Ross McQueenie, et al.
Arthritis Research & Therapy|March 2, 2006
Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritisSarah L Jongbloed, M Cristina Lebre, Alasdair R Fraser, et al.
RMD Open|June 28, 2019
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a <i>post hoc</i> analysis of a phase III trialIain B McInnes, Gianfranco Ferraccioli, Maria-Antonietta D'Agostino, et al.
Immunology Letters|March 23, 2011
Putative existence of reciprocal dialogue between Tfh and B cells and its impact on infectious and autoimmune diseaseAgapitos Patakas, Andrew M Platt, John P Butcher, et al.
Journal of Comparative Effectiveness Research|September 20, 2018
Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysisIain B McInnes, Peter Nash, Christopher Ritchlin, et al.
Annals of the Rheumatic Diseases|May 1, 1996
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritisI B McInnes, D Porter, E A Murphy, et al.
Gait & Posture|October 5, 2010
A reliability study of biomechanical foot function in psoriatic arthritis based on a novel multi-segmented foot modelElaine Hyslop, James Woodburn, Iain B McInnes, et al.
Pageof 54

Showing results (211-220 of 537) with videos related to

Sort By:
Pageof 54
Rheumatology and Therapy|August 9, 2024
Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect ComparisonPhilip J Mease, Richard B Warren, Peter Nash, et al.
The Lancet. Rheumatology|January 17, 2024
Precision medicine in psoriatic arthritis: how should we select targeted therapies?Hussein Al-Mossawi, Leonie S Taams, Carl S Goodyear, et al.
Rheumatology (Oxford, England)|July 15, 2016
MicroRNA-155 regulates monocyte chemokine and chemokine receptor expression in Rheumatoid ArthritisAziza Elmesmari, Alasdair R Fraser, Claire Wood, et al.
Rheumatology (Oxford, England)|July 28, 2014
The active metabolite of spleen tyrosine kinase inhibitor fostamatinib abrogates the CD4⁺ T cell-priming capacity of dendritic cellsAndrew M Platt, Robert A Benson, Ross McQueenie, et al.
Arthritis Research & Therapy|March 2, 2006
Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritisSarah L Jongbloed, M Cristina Lebre, Alasdair R Fraser, et al.
RMD Open|June 28, 2019
Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a <i>post hoc</i> analysis of a phase III trialIain B McInnes, Gianfranco Ferraccioli, Maria-Antonietta D'Agostino, et al.
Immunology Letters|March 23, 2011
Putative existence of reciprocal dialogue between Tfh and B cells and its impact on infectious and autoimmune diseaseAgapitos Patakas, Andrew M Platt, John P Butcher, et al.
Journal of Comparative Effectiveness Research|September 20, 2018
Secukinumab for psoriatic arthritis: comparative effectiveness versus licensed biologics/apremilast: a network meta-analysisIain B McInnes, Peter Nash, Christopher Ritchlin, et al.
Annals of the Rheumatic Diseases|May 1, 1996
Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritisI B McInnes, D Porter, E A Murphy, et al.
Gait & Posture|October 5, 2010
A reliability study of biomechanical foot function in psoriatic arthritis based on a novel multi-segmented foot modelElaine Hyslop, James Woodburn, Iain B McInnes, et al.
Pageof 54